B. Motheral

发表

The use of claims databases for outcomes research: rationale, challenges, and strategies.

B. Motheral, K. Fairman, 1997, Clinical therapeutics.

PRACTITIONER UPDATE Outcomes Management: The Why, What, and How of Data Collection

B. Motheral, 1997 .

Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s).

D. Mager, E. Cox, B. Motheral, 2003, The American journal of managed care.

Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002.

A. Gelenberg, B. Motheral, T. Delate, 2004, Psychiatric services.

The Effect of a Closed Formulary in the Face of Real-Life Enrollment and Disenrollment Patterns

J. Shaw, B. Motheral, T. Delate, 2000 .

Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization

B. Motheral, K. Fairman, Brenda Motheral, 2001, Medical care.

Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample.

D. Mager, E. Cox, B. Motheral, 2003, Pediatrics.

The effect of a closed formulary on prescription drug use and costs.

B. Motheral, R. Henderson, 1999, Inquiry : a journal of medical care organization, provision and financing.

Patterns of use of sildenafil among commercially insured adults in the United States: 1998–2002

B. Motheral, T. Delate, V. A. Simmons, 2004, International Journal of Impotence Research.

Telephone-based disease management: why it does not save money.

B. Motheral, 2011, The American journal of managed care.

Randomized Controlled Trial of a Dose Consolidation Program

B. Motheral, K. Fairman, T. Delate, 2004, Journal of managed care pharmacy : JMCP.

Achieving Long‐Term Continuance of Menopausal ERT/HRT: Consensus Opinion of The North American Menopause Society

J. Cramer, D. Jeffe, M. Rothert, 1998, Menopause.

A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.

Peter Davey, Brenda Motheral, John Brooks, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Gender- and Age-Related Prescription Drug Use Patterns

C. Roe, B. Motheral, Catherine M Roe, 2002, The Annals of pharmacotherapy.

Principles of Pharmacoeconomics

E. Cox, B. Motheral, C. Daniels, 2015 .

Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population.

D. Mager, B. Motheral, T. Delate, 2005, The American journal of managed care.

Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products.

Marsha A Raebel, Brenda Motheral, Gurvaneet Randhawa, 2015, Journal of managed care & specialty pharmacy.

Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization.

M. Rich, C. Roe, B. Motheral, 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure.

M. Rich, C. Roe, B. Motheral, 1999, American heart journal.

Understanding and evaluating original research articles.

B. Motheral, T. R. Jackson, 1999, Journal of the American Pharmaceutical Association.

Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication

B. Motheral, K. Fairman, 2003, Journal of managed care pharmacy : JMCP.

The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.

B. Motheral, R. Henderson, 1999, The American journal of managed care.

Pharmaceutical Step-Therapy Interventions: A Critical Review of the Literature

B. Motheral, 2011, Journal of managed care pharmacy : JMCP.

Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy.

D. Mager, M. Frisse, E. Cox, 2003, The American journal of managed care.

Health Plan Member Experience With Point-of-Service Prescription Step Therapy

E. Cox, B. Motheral, R. Henderson, 2004, Journal of managed care pharmacy : JMCP.

Plan-sponsor savings and member experience with point-of-service prescription step therapy.

E. Cox, B. Motheral, R. Henderson, 2004, The American journal of managed care.

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.

B. Motheral, K. Fairman, R. Henderson, 2003, Clinical therapeutics.

Predictors of satisfaction of health plan members with prescription drug benefits.

B. Motheral, Shelly M. Heinle, 2004, American Journal of Health-System Pharmacy.

Helicobacter Pylori Eradication in Clinical Practice: Retreatment Rates and Costs of Competing Regimens

B. Motheral, K. Fairman, 2000, The Annals of pharmacotherapy.

Changes in PBM Business Practices in 2019: True Innovation or More of the Same?

B. Motheral, K. Fairman, 2020, Journal of managed care & specialty pharmacy.

Research Methodology: Hypotheses, Measurement, Reliability, and Validity

B. Motheral, 2015 .

Assessing the Value of the Quality of Health Economic Studies (QHES)

B. Motheral, 2003, Journal of managed care pharmacy : JMCP.

Is Value-Based Value Wasted? Examining Value-Based Insurance Designs Through the Lens of Cost-Effectiveness

B. Motheral, S. Melnick, 2010, Journal of managed care pharmacy : JMCP.